Trial Site Detail
Drug: |
IDRX-42 |
|||
|---|---|---|---|---|
Trial: |
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
University of Chicago5841 S. Maryland Ave |
Principal Investigator: |
Janet Chin |
|---|---|
Contact: |
Clinical Trials Office, 773-834-7424 |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
University of Chicago Website: |
https://med-www02.bsd.uchicago.edu/crc_web/SR/internet/DiseaseSites.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.